Ausgabe 2/2009
Inhalt (22 Artikel)
The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review
Michelle Peate, Bettina Meiser, Martha Hickey, Michael Friedlander
The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer
Tyler Lahusen, Ralf T. Henke, Benjamin L. Kagan, Anton Wellstein, Anna T. Riegel
The hedgehog pathway as a therapeutic target for treatment of breast cancer
M. F. Barginear, M. Leung, D. R. Budman
Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal–epithelial interactions
Osvaldo Pontiggia, Vanina Rodriguez, Victoria Fabris, Diego Raffo, Viviana Bumaschny, Gabriel Fiszman, Elisa Bal de Kier Joffé, Marina Simian
Three-dimensional pathological size assessment in primary breast carcinoma
Uwe Güth, Denise Brenckle, Dorothy Jane Huang, Andreas Schötzau, Carsten Thomas Viehl, Holger Dieterich, Wolfgang Holzgreve, Edward Wight, Gad Singer
Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer
Maurice P. H. M. Jansen, Kirsten Ruigrok-Ritstier, Lambert C. J. Dorssers, Iris L. van Staveren, Maxime P. Look, Marion E. Meijer-van Gelder, Anieta M. Sieuwerts, Jozien Helleman, Stefan Sleijfer, Jan G. M. Klijn, John A. Foekens, Els M. J. J. Berns
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition
Frank Köster, Jörg B. Engel, Andrew V. Schally, Arnd Hönig, Andreas Schröer, Stephan Seitz, Florian Hohla, Olaf Ortmann, Klaus Diedrich, Stefan Buchholz
Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant
Clare A. Thibodeaux, Xuefeng Liu, Gary L. Disbrow, Yiyu Zhang, Janice D. Rone, Bassem R. Haddad, Richard Schlegel
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
Stella Mook, Marjanka K. Schmidt, Giuseppe Viale, Giancarlo Pruneri, Inge Eekhout, Arno Floore, Annuska M. Glas, Jan Bogaerts, Fatima Cardoso, Martine J. Piccart-Gebhart, Emiel T. Rutgers, Laura J. van’t Veer
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
Yi Zhang, Anieta M. Sieuwerts, Michelle McGreevy, Graham Casey, Tanja Cufer, Angelo Paradiso, Nadia Harbeck, Paul N. Span, David G. Hicks, Joseph Crowe, Raymond R. Tubbs, G. Thomas Budd, Joanne Lyons, Fred C. G. J. Sweep, Manfred Schmitt, Francesco Schittulli, Rastko Golouh, Dmitri Talantov, Yixin Wang, John A. Foekens
Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial
Jill Hervik, Odd Mjåland
Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
Giuseppe Viale, Nicole Rotmensz, Patrick Maisonneuve, Luca Bottiglieri, Emilia Montagna, Alberto Luini, Paolo Veronesi, Mattia Intra, Rosalba Torrisi, Anna Cardillo, Elisabetta Campagnoli, Aron Goldhirsch, Marco Colleoni
A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow
Kjersti Tjensvoll, Bjørnar Gilje, Satu Oltedal, Victor F. Shammas, Jan Terje Kvaløy, Reino Heikkilä, Oddmund Nordgård
A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease
Thomas E. Rohan, Abdissa Negassa, Rowan T. Chlebowski, Clementina D. Ceria-Ulep, Barbara B. Cochrane, Dorothy S. Lane, Mindy Ginsberg, Sylvia Wassertheil-Smoller, David L. Page
Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial
S. Del Barco, R. Colomer, L. Calvo, I. Tusquets, E. Adrover, P. Sánchez, J. Rifà, J. De la Haba, J. A. Virizuela
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy
Marco Colleoni, Vincenzo Bagnardi, Nicole Rotmensz, Richard D. Gelber, Giuseppe Viale, Giancarlo Pruneri, Paolo Veronesi, Rosalba Torrisi, Anna Cardillo, Emilia Montagna, Elisabetta Campagnoli, Alberto Luini, Mattia Intra, Viviana Galimberti, Eloise Scarano, Giulia Peruzzotti, Aron Goldhirsch
Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
Matthew J. Ellis, William R. Miller, Yu Tao, Dean B. Evans, Hilary A. Chaudri Ross, Yasuhiro Miki, Takashi Suzuki, Hironobu Sasano
BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research
Susan L. Neuhausen, Hilmi Ozcelik, Melissa C. Southey, Esther M. John, Andrew K. Godwin, Wendy Chung, Jeniffer Iriondo-Perez, Alexander Miron, Regina M. Santella, Alice Whittemore, Irene L. Andrulis, Saundra S. Buys, Mary B. Daly, John L. Hopper, Daniela Seminara, Ruby T. Senie, Mary Beth Terry
Complementary and alternative therapies among very long-term breast cancer survivors
C. L. Carpenter, P. A. Ganz, L. Bernstein
CHEK2 1100delC and male breast cancer in the Netherlands
Marijke Wasielewski, Michael A. den Bakker, Ans van den Ouweland, Marion E. Meijer-van Gelder, Henk Portengen, Jan G. M. Klijn, Hanne Meijers-Heijboer, John A. Foekens, Mieke Schutte
Dietary isoflavone intake and breast cancer risk in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians
Motoki Iwasaki, Gerson Shigeaki Hamada, Ines Nobuko Nishimoto, Mario Mourão Netto, Juvenal Motola Jr., Fábio Martins Laginha, Yoshio Kasuga, Shiro Yokoyama, Hiroshi Onuma, Hideki Nishimura, Ritsu Kusama, Minatsu Kobayashi, Junko Ishihara, Seiichiro Yamamoto, Tomoyuki Hanaoka, Shoichiro Tsugane
Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women
Gordon Fehringer, Hilmi Ozcelik, Julia A. Knight, Andrew D. Paterson, Norman F. Boyd